Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 151,805 | 27,439 | 38,282 | 45,891 | 32,811 |
| Gross Profit | 151,805 | 27,439 | 38,282 | 45,891 | 32,811 |
| Operating Expenses | 110,252 | 90,760 | 103,164 | 77,759 | 61,043 |
| Operating Income | 41,553 | -63,321 | -64,882 | -31,868 | -28,232 |
| Other Income | 2,813 | 449 | 1,510 | 1,944 | 1,414 |
| Pre-tax Income | 44,366 | -62,872 | -63,372 | -29,924 | -26,818 |
| Net Income Continuous | 44,366 | -62,872 | -63,374 | -29,924 | -26,818 |
| Net Income | $44,366 | $-62,872 | $-63,374 | $-29,924 | $-26,818 |
| EPS Basic Total Ops | 0.42 | -0.60 | -0.61 | -0.29 | -0.26 |
| EPS Basic Continuous Ops | 0.42 | -0.60 | -0.61 | -0.29 | -0.26 |
| EPS Diluted Total Ops | 0.41 | -0.60 | -0.61 | -0.29 | -0.26 |
| EPS Diluted Continuous Ops | 0.41 | -0.60 | -0.61 | -0.29 | -0.26 |
| EBITDA(a) | $44,756 | $-61,028 | $-62,254 | $-29,922 | $-25,819 |